openPR Logo
Press release

Crohn’s Disease Market 2018-2022 to Grow with Allergan, Inc., AbbVie Inc., Bayer AG, Pfizer Inc., and Johnson & Johnson Services, Inc. etc. Dominating

09-25-2018 08:54 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

Crohn’s Disease Market

Crohn’s Disease Market

Crohn's Disease is a type of Inflammatory Bowel Disease (IBD) that affects any part of the gastrointestinal tract from mouth to anus. Increasing demand for biologics for treating or preventing bowel disorders such as ulcerative collates and crohn's disease is driving the overall growth of the crohn's disease market. High cost of treatment is the major factor that is restricting the market growth. Crohn’s Disease Market is Expected to Grow at a CAGR of 3% from 2016 to 2022.

Get Sample Report @ https://www.marketresearchfuture.com/sample_request/2344

Global Crohn’s Disease Market has been evaluated as growing market and expected that the market will reach high growth figures in the coming future. Crohn's disease is a type of inflammatory bowel disease (IBD), caused by a combination of environmental, immune and bacterial factors in genetically prone individuals. There are no medications, drugs or surgical procedures that can cure or prevent Crohn's disease. It is expected that the disease affects about 3.2 per 1,000 people in Europe and North America. It is less common in Asia and Africa. Rates have, however, been growing, particularly in the developing world, since last few years.

Major factors leading to the growth of the market includes higher preference for symptomatic therapeutic, better treatment of inflammatory bowel diseases, arrival of enhanced drugs and healthier investments in R&D programs. High cost of treatment and lack of early diagnosis techniques are the major factor restricting the market growth.

Global Crohn’s Disease Market - Key Players

Key players profiled in the report are

Allergan, Inc.
AbbVie Inc.
Takeda Pharmaceutical Company Limited
Bayer AG
UCB S.A.
Perrigo Company plc.
Pfizer Inc.
Johnson & Johnson Services, Inc.
Ferring B.V.

Crohn’s Disease Market - Industry/Innovations/Related News

March 27, 2018 – Researchers at the University of Alberta (Canada), published the study of the potential biomarkers they have developed to help reduce the suffering of Crohn’s disease patients. These scientists used high performance liquid chromatography with mass spectrometry and created a profile of potential biomarkers.

April 03, 2018 - TiGenix NV (Belgium), a global cell therapy company and Takeda Pharmaceutical (Japan), the largest global pharmaceutical company, together announced approval from the EC (European Commission) for the treatment Alofisel (darvadstrocel) they have developed to treat the complex perianal fistulae in adult patients with non-active (mildly active) luminal Crohn’s disease. This is the first allogeneic stem cell therapy (originating from donor stem cells) to receive central marketing authorisation (MA) approval in Europe.

Get Discount on Report @ https://www.marketresearchfuture.com/check-discount/2344

Crohn’s Disease Market – Segmentation

Global Crohn’s Disease Market is segmented in to 3 Key dynamics for an easy grasp and enhanced understanding.

By Procedures: Comprises - Colonoscopy, Flexible Sigmoidoscopy, Magnetic Resonance Imaging (MRI), Computerized Tomography (CT), Capsule Endoscopy, and Small Bowel Imaging & Double-Balloon Endoscopy among others.

By Drug Types: Anti-Diarrheal, Antibiotics, Immune System Suppressors, Anti-Inflammatory Drugs Pain Relievers among others.

By Regions: North America, Europe, APAC and Rest of the World.

Global Crohn’s Disease Market – Regional Analysis

North America accounts for the largest market share of the global Crohn’s Disease Market followed by the Europe & Asia Pacific regions. The North America market is growing due to the largest contribution from the significantly growing market of the US.

On the other hand, growth of the world’s second largest market for Crohn’s Disease, (Europe) is driven by the higher per capita income and strong healthcare penetration in the region.

While Asia Pacific market for the Crohn’s Disease is expected to perceive an exponential growth. The market growth will be led by China and India owing to the huge population and the low cost of Crohn’s drugs.

To Know More Enquire @ https://www.marketresearchfuture.com/enquiry/2344

Major Table of Content

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

Continued….

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Crohn’s Disease Market 2018-2022 to Grow with Allergan, Inc., AbbVie Inc., Bayer AG, Pfizer Inc., and Johnson & Johnson Services, Inc. etc. Dominating here

News-ID: 1259832 • Views: …

More Releases from Market Research Future

9-Decanoic Acid Methyl Ester Market Poised for Strong 6.59% CAGR Growth Through 2035
9-Decanoic Acid Methyl Ester Market Poised for Strong 6.59% CAGR Growth Through …
The 9-decanoic acid methyl ester market is a growing sector driven by the increasing demand for bio-based and sustainable chemical products across various industries. With its unique properties, it finds application in flavors and fragrances, pharmaceuticals, personal care, and as a chemical intermediate. The market is projected to expand significantly in the coming years. Market Overview and Size The global 9-decanoic acid methyl ester market was valued at USD 230.0 million in…
Washable Marker Market Poised for 3.54% CAGR Growth During 2024-2032
Washable Marker Market Poised for 3.54% CAGR Growth During 2024-2032
The washable marker market is a dynamic and growing segment within the broader stationery and art supplies industry. Driven by a blend of consumer demands for safety, convenience, and sustainability, the market is experiencing consistent expansion, particularly within the education and home-use sectors. While faced with some challenges, the industry's future looks promising, propelled by product innovation and evolving consumer trends. Get Sample @ https://www.marketresearchfuture.com/sample_request/41217 Market Size and Growth The global washable…
Phone Car Mounts Market to Reach USD 7.37 Billion by 2034, Growing at 6.47% CAGR
Phone Car Mounts Market to Reach USD 7.37 Billion by 2034, Growing at 6.47% CAGR
The phone car mounts market, a critical sub-segment of the broader automotive accessories industry, is experiencing robust growth driven by a convergence of technological advancements, evolving consumer behavior, and increasingly stringent road safety regulations. As smartphones become indispensable for navigation, communication, and in-car entertainment, the demand for secure and convenient hands-free solutions continues to escalate. The global phone car mounts market was valued at USD 3.93 billion in 2024 and…
Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR by 2032
Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR …
Market Overview: The Intravenous (IV) Solution Market is estimated to be valued at USD 13.9 billion in 2023 and is projected to reach USD 26.60 billion by 2032, expanding at a compound annual growth rate (CAGR) of 7.70% from 2024 to 2031. The market growth is attributed to the rising prevalence of chronic diseases, growing hospitalization rates, and increasing surgical procedures that require IV fluid administration. Intravenous solutions are critical…

All 5 Releases


More Releases for Crohn

Global IBD Ulcerative Colitis And Crohn S Disease Treatment Industry Poised for …
The IBD Ulcerative Colitis And Crohn S Disease Treatment Market research report offers crucial insights into how the industry is evolving, highlighting key drivers of growth and the main revenue streams expected between 2024 and 2032. Similar to a compass, it helps businesses navigate the market's complexities by showcasing both the present situation and the newest developments influencing its direction. For businesses, stakeholders, and industry participants, this report serves as…
Global Companion Animal Specialty Drugs and Crohn s Disease Drug (COVID-19 Imapa …
The Companion Animal Specialty Drugs Market ( https://bit.ly/31KDIZZ ) report is intended to function as a supportive means to assess the Companion Animal Specialty Drugs market along with the complete analysis and clear-cut statistics related to this market. In other words, the report would provide an up-to-date study of the market in terms of its latest trends, present scenario, and the overall market situation. Further, it will also help the…
Crohn’s Disease Drugs Market Research and Clinical Analysis 2020 - Bayer AG, Amg …
The Crohn's Disease Drugs Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Order a Copy of…
Crohn s Disease Drug Market to Witness Huge Growth by 2025 | AbbVie, Janssen Bio …
HTF MI recently introduced Global Crohn s Disease Drug Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are AbbVie, Janssen Biotech, UCB, Amgen, Tillotts Pharma & Takeda…
Crohn Disease Market 2018 by its Scientific Reviews, Clinical Application and Ke …
Global Crohn Disease Market Professional Survey Report 2018 to 2025 presents an in-depth assessment of the Crohn Disease Market including enabling key trends, market drivers, challenges, standardization, regulatory landscape, deployment models, operator case studies, opportunities, future roadmap, value chain, ecosystem player profiles and strategies. The report also presents forecasts for Crohn Disease Market investments from 2018 till 2025. This study answers several questions for stakeholders, primarily which market segments…
Crohn Disease Market Set for Expansive Growth by 2022
This report studies the global Crohn Disease market, analyzes and researches the Crohn Disease development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like Johnson & Johnson Pfizer Sanofi Merck GSK AbbVie Takeda Ferring UCB Boehringer Ingelheim Ask for sample copy @ http://www.researchtrades.com/request-sample/1117798 Market segment by Regions/Countries, this report covers United States EU Japan China India Southeast Asia Market segment by Type, Crohn Disease can be split into Small Intestine and Ileocephalitis Colon Disease Market segment…